These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28583368)

  • 41. Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.
    Berman K; Brodaty H
    CNS Drugs; 2004; 18(12):807-25. PubMed ID: 15377170
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale.
    Prasad KN; Cole WC; Hovland AR; Prasad KC; Nahreini P; Kumar B; Edwards-Prasad J; Andreatta CP
    Curr Opin Neurol; 1999 Dec; 12(6):761-70. PubMed ID: 10676761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebral vasomotor reactivity in neurodegenerative diseases.
    Smoliński Ł; Członkowska A
    Neurol Neurochir Pol; 2016; 50(6):455-462. PubMed ID: 27553189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parkinson's disease, motoneuron disease and Alzheimer's disease: origins and interrelationship.
    Calne DB; Eisen A
    Adv Neurol; 1990; 53():355-60. PubMed ID: 2239477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent progress in neurodegenerative disorder research in China.
    Zhou J
    Sci China Life Sci; 2010 Mar; 53(3):348-355. PubMed ID: 20596930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. From small to big molecules: how do we prevent and delay the progression of age-related neurodegeneration?
    Ho YS; Poon DC; Chan TF; Chang RC
    Curr Pharm Des; 2012; 18(1):15-26. PubMed ID: 22211681
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dynamic Handwriting Analysis for the Assessment of Neurodegenerative Diseases: A Pattern Recognition Perspective.
    Impedovo D; Pirlo G
    IEEE Rev Biomed Eng; 2019; 12():209-220. PubMed ID: 29993722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Changes in olfaction during ageing and in certain neurodegenerative diseases: up-to-date].
    Bianchi AJ; Guépet-Sordet H; Manckoundia P
    Rev Med Interne; 2015 Jan; 36(1):31-7. PubMed ID: 25304170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Immunity and Inflammation in the Pathophysiology of Neurodegenerative Diseases.
    Fakhoury M
    Neurodegener Dis; 2015; 15(2):63-9. PubMed ID: 25591815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects.
    Danysz W
    Expert Opin Investig Drugs; 2001 May; 10(5):985-9. PubMed ID: 11424902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
    Yang Y; Jiang S; Yan J; Li Y; Xin Z; Lin Y; Qu Y
    Cytokine Growth Factor Rev; 2015 Feb; 26(1):47-57. PubMed ID: 25280871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurodegenerative disease and the neuroimmune axis (Alzheimer's and Parkinson's disease, and viral infections).
    Ringheim GE; Conant K
    J Neuroimmunol; 2004 Feb; 147(1-2):43-9. PubMed ID: 14741426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The neurodegenerative mitochondriopathies.
    Swerdlow RH
    J Alzheimers Dis; 2009; 17(4):737-51. PubMed ID: 19542616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Welding occupations and mortality from Parkinson's disease and other neurodegenerative diseases among United States men, 1985-1999.
    Stampfer MJ
    J Occup Environ Hyg; 2009 May; 6(5):267-72. PubMed ID: 19204865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases.
    Migliore L; Fontana I; Colognato R; Coppede F; Siciliano G; Murri L
    Neurobiol Aging; 2005 May; 26(5):587-95. PubMed ID: 15708433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Substance P and neurodegenerative disorders. A speculative review.
    Barker R
    Neuropeptides; 1991 Oct; 20(2):73-8. PubMed ID: 1724684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Can we prevent Parkinson's and Alzheimer's disease?
    Kedar NP
    J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?
    Ashrafian H; Harling L; Darzi A; Athanasiou T
    Metab Brain Dis; 2013 Sep; 28(3):341-53. PubMed ID: 23653255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin D deficiency and its role in neurological conditions: A review.
    Mpandzou G; Aït Ben Haddou E; Regragui W; Benomar A; Yahyaoui M
    Rev Neurol (Paris); 2016 Feb; 172(2):109-22. PubMed ID: 26867662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.